NDAINJECTIONINJECTABLE
Approved
Jun 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RBC-SCAN is a technetium TC-99m labeled red blood cell imaging kit used for radionuclide imaging and cardiac blood pool studies. It is a diagnostic radiopharmaceutical that binds to red blood cells to visualize blood flow and cardiac function. The kit enables clinicians to assess cardiac viability and detect abnormalities in myocardial perfusion.
LOE Approaching
Product approaching loss of exclusivity with low competitive pressure (30%), indicating a niche diagnostic market with limited growth opportunities and small brand support teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
RBC-SCAN has zero linked job openings, reflecting a small, niche diagnostic product with minimal hiring and limited career trajectory. Working on this product offers narrow exposure primarily to mature-market commercial and operational functions rather than high-growth innovation areas.
Product ManagerSales Representative
Worked on RBC-SCAN at AcadeMab Biomedical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.